• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Virtual reality treatment may be helpful in treating anxiety disorders

byNicholas Ng Fat HingandAshley Jackson
August 16, 2023
in Psychiatry, Wellness
Reading Time: 2 mins read
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Share on FacebookShare on Twitter

1. In this systematic review and meta-analysis, virtual reality (VR) treatments were associated with lower anxiety symptoms when compared to passive control groups.

2. However, in comparison to active controls, VR treatments were not statistically superior.

Evidence Rating Level: 1 (Excellent)

Virtual reality (VR) is a potential treatment option for mental health disorders which may be desirable given the high prevalence of anxiety disorders and the lack of mental health resources. Current meta-analyses on VR applications have not been updated for several years and were limited in the anxiety disorders investigated. As a result, the objective of the present study was to update and review the impact of current VR applications in the treatment of anxiety disorders.

Of 903 identified records, 17 (n=827 participants) studies were included from various databases from April 2011 to April 2021. Studies were included if they were randomized controlled trials and participants had a diagnosed anxiety disorder, received VR as a treatment, and were evaluated using validated self-report measurements and behavioral assessment/avoidance tasks (BAT). Studies were excluded if they were comparing two different VR interventions, if participants did not have a diagnosis of anxiety disorder, or if there was a lack of data from intervention and control groups. The review was performed using PRISMA guidelines. The risk of bias was assessed using the risk of bias assessment tool developed by the Cochrane Collaboration. The primary outcome was the difference in anxiety symptoms between VR treatment and control groups.

The results demonstrated that, compared to passive control groups (e.g., waiting list control groups or psychoeducation), patients who used VR applications had lower anxiety symptoms. However, when compared to active control groups (e.g., cognitive behavioral therapy (CBT) or exposure therapy), the benefit of VR treatment did not reach statistical significance. Despite these findings, the study was limited by the heterogeneity of the included studies, which may have affected the results. Nonetheless, the present study provided evidence that VR applications may be an effective treatment for anxiety disorders, especially when the gold-standard treatment is unavailable.

RELATED REPORTS

Video mental health care may have clinical advantages versus phone or in-person visits

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

Click to read the study in Journal of Behaviour Therapy and Experimental Psychiatry

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietycognitive behavioral therapy (CBT)exposure therapymental healthvirtual realitywellness
Previous Post

Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer

Next Post

#VisualAbstract: Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT)

RelatedReports

Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026
Next Post
#VisualAbstract: Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT)

#VisualAbstract: Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT)

Orforglipron may be a safe and effective oral GLP-1 agonist for treatment of type 2 diabetes

30% and 60% inspired oxygen fraction intraoperatively have similar prevalence of postoperative atelectasis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
  • 2 Minute Medicine Rewind September 28, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.